Release Date: 30/11/12 14:10 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 274.58KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%